Grace Therapeutics, Inc. (GRCE)
R&D to Revenue
0.00%
Fiscal year · Period ending:
GRCE R&D to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
GRCE FY R&D/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
GRCE r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 2,129.085% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 14,244.2279% | |
| 2,346.407% | |
| 1,209.7477% | |
| 415.4976% | |
| 29,811.7422% | |
| 5,754.5242% | |
| 0% | |
| 0% |